Influence of Obesity Diagnosis With Organ Dysfunction, Mortality, and Resource Use Among Children Hospitalized With

Nidhi Maley1, Achamyeleh Gebremariam1, Folafoluwa Odetola1

  • 11 Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA.

Insights

Obesity in children hospitalized with infection was linked to more organ dysfunction, longer stays, and higher costs. However, illness severity influenced these outcomes, not mortality.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Public health and epidemiology

Background:

  • Sepsis, a life-threatening response to infection, is a leading cause of child mortality.
  • Obesity is associated with chronic inflammation, but its impact on pediatric infection and sepsis is not well understood.
  • Understanding obesity's role in pediatric infections is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between obesity and outcomes in children hospitalized with infection.
  • To evaluate the impact of obesity on organ dysfunction, mortality, hospital stay duration, and charges.
  • To explore how illness severity modifies these associations.

Main Methods:

  • Retrospective analysis of a national dataset (2009 Kids' Inpatient Database).
  • Inclusion of hospitalizations for children aged 0 to 20 years with infection.
  • Comparison of outcomes between obese and non-obese pediatric patients.

Main Results:

  • Obese children hospitalized for infection experienced higher rates of organ dysfunction (7.35% vs. 5.5%).
  • Obese patients had significantly longer hospital stays (4.1 vs. 3.5 days) and higher medical charges (US$29,019 vs. US$21,200).
  • While in-hospital mortality did not differ by obesity status, illness severity influenced organ dysfunction, hospital stay, and charges.

Conclusions:

  • Obesity in hospitalized children with infection is associated with increased organ dysfunction, longer stays, and higher costs, but not mortality.
  • Illness severity plays a key role in mediating the relationship between obesity and these adverse outcomes.
  • Findings highlight the need for targeted strategies to manage obesity's impact on pediatric infections and sepsis.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
335
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
368
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
279
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K